Skip to content

Role of Balrasayana "Manjisthadi Ghrita" in Preventing Child diseases and boosting proper health.

"A Clinical Trial to Evaluate the Role of Manjisthadi Ghrita as Balrasayana in Preventive Child Health Careâ??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013962
Enrollment
60
Registered
2018-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1-weight for age between 70 - 79% (nutritional grade 1 according to IAP classification ) 2-Repeated illness like RTIs,GIT infections ,skin allergies etc 3-Poor school performance

Interventions

Intervention1: Trial drug- Manjisthadi Ghrita: oral administration of 1ml/kg/day in 2 divided doses for 60 days with honey and luke warm water Control Intervention1: Sugar based placebo syrup: oral ad

Sponsors

State Ayurvedic College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Children aged between 5 to 8 year. 2-completely vaccinated children according to National Immunization Schedule. 3-Children having weight for age 70-79% i.e- nutritional grade 1st according to IAP classification. 4-Children having repeated illness like respiratory tract infection, GIT tract infection, skin allergies, etc. 4. poor school performance

Exclusion criteria

Exclusion criteria: •Children age less than 5 year and more than 8 year. •Incompletely vaccinated children according to National Immunization Schedule. •Children suffering from any systemic or congenital anomaly. •Children suffering from any psychological illness. •Children having severe intellectual disability and mental retardation.

Design outcomes

Primary

MeasureTime frame
.improvement in loss of appetite .effective weight gain Recurrent infection rate decreasesTimepoint: .2 weeks .4 weeks

Secondary

MeasureTime frame
. effective weight gain. . improvement in the symptoms of repeated illness. . improvement in I.Q level. Timepoint: .8 weeks .6-8weeks .6-8weeks

Countries

India

Contacts

Public ContactDr Laxmi

State Ayurvedic College and Hospital Lucknow

lakshmiomsingh@gmail.com9792446688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026